SCHEMBL4730129

SCHEMBL4730129

CCOC(=O)c1ccc(-c2ccc(Cl)nc2)nc1C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.58
NPC1 O15118 5/20 0.58
CASP3 P42574 2/20 0.58
SENP8 Q96LD8 2/20 0.58
SENP7 Q9BQF6 2/20 0.58
SENP6 Q9GZR1 2/20 0.58
ATM Q13315 2/20 0.58
SMN1; SMN2 Q16637 8/20 0.54
MAPT P10636 2/20 0.54
NFKB1 P19838 1/20 0.54
NFKB2 Q00653 1/20 0.54
RELA Q04206 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
MDM2 Q00987 1/20 0.49
KDM4E B2RXH2 5/20 0.46
ALDH1A1 P00352 5/20 0.46
HPGD P15428 3/20 0.46
HTT P42858 1/20 0.46
HSD17B10 Q99714 1/20 0.44
DGAT1 O75907 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9647875 0.85 SMN1; SMN2 (0.74) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL4728543 0.84 RAB9A (0.44) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL25866687 0.82 SMN1; SMN2 (0.65) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL609984 0.81 KDM4E (0.54) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL4728732 0.81 RAB9A (0.55) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL4386607 0.80 RAB9A (0.74) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL4434197 0.79 MDM2 (0.67) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL31339958 0.78 RAB9A (0.60) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL31220216 0.78 RAB9A (0.54) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL29678523 0.77 RAB9A (0.59) RAB9ANPC1CASP3SENP8SENP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008034579-A1 2-HETEROCYCLYL-5-PHENOXYMETHYLPYRIDINE DERIVATIVES AS ANTICANCER AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2008-03-27 WO disclosed